Abstract:TN THE NATIONAL Health Service nearly 100 per cent of the population are on doctors' lists. In favourable circumstances this could provide the opportunity to study records of families and to extract information in relation to heritable morbidity. The family doctor in the National Health Service has thus got an unparalleled opportunity for family studies, provided of course, he has been keeping records and provided he has not a too rapidly changing practice population. In our group practice partnership, comprising about 18,000 patients, we have a good opportunity to study the possibility of collating eugenically relevant information in families. It is perhaps appropriate here to describe the type of practice we are working in. There are six principals and a recently appointed assistant. The district is a semi-industrial re-housing area in Edinburgh which has gradually extended during the past twenty years. There is a predominance f occupations in Registrar General Social Class and v, with a fair number of iii and a few in ii. e housing consists mainly of tenements altthough there is a large area of prefabricated ouses, single family houses, along with some semi-detached villa type of buildings. There are fcw owners of their own houses, nearly ninety per cent being rented from the local authority. The kcommunity is religiously of a mixed nature, with a slight preponderance of non-catholics. We So nduct our practices in the main from two specially adapted buildings with nursing and secretarial staff available, and close co-operation with health visitors and the social services. The National Health Service records by themselves are not very-helpful, as there is no ready way of obtaining the information on a quantitative basis about any one condition, without going through all the records. If the information extracted from a National Health Service Practice is to be of any use, it would have to be based on a sufficiently large number of patients. To obtain data on this scale from the existing records would require repeated "going through" the National Health Service records which is a practical impossibility. In 1958 we began to plan an investigation to explore the possibilities of family doctor records in the National Health Service. A pilot survey of the patients with letter "A" showed that we would have a monumental task if we decided to extract all the information already recorded. What was required was a recording system of coded information allowing ready access to relevant information for the conduct of further, and particularly long term studies. Very early on we realized that in this group practice it would be impossible to code and index all morbidity met with in our daily work. We decided to limit ourselves to the clinical conditions which produce a pathology with permanent changes, viz. mainly all chronic conditions, congenital abnormalities. Another objective was to demonstrate that such a system of recording, coding and indexing could be used

Family follow-up studies into the eugenic aspects of morbidity: Interim progress report.

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Systemic Administration of Combinatorial Dsirnas Via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice

In Vitro Selection of G-Rich Rna Aptamers That Target Hiv-1 Integrase

Genome Scale Screening Identification of SaCas9/gRNAs for Targeting HIV-1 Provirus and Suppression of HIV-1 Infection

A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region

An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane

In Silico Identification of Novel Aromatic Compounds As Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4

High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase

First measurement of unpolarized semi-inclusive deep-inelastic scattering cross sections from a 3 He target

Multitargeted Drug Design Strategy for Discovery of Short-Peptide-based HIV-1 Entry Inhibitors with High Potency

Lentiviral Delivery of RNAi Effectors Against HIV-1

Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1

Design, Synthesis and Biological Evaluation of Thiazolo[3, 2-A]pyrimidine Derivatives As Novel RNase H Inhibitors

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41

Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Exploring the Stereochemistry of CXCR4-peptide Recognition and Inhibiting HIV-1 Entry with D-peptides Derived from Chemokines.

In Silico Identification of High-Affinity Ligands of the Hiv-1 Gp120 Protein, Potential Peptidomimetics of Neutralizing Antibody N6

Antiviral Stratagems against HIV-1 Using RNA Interference (RNAi) Technology

Rational Design of Self-Assembled RNA Nanostructures for HIV-1 Virus Assembly Blockade.

Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors